Abstract
Objectives
Osteosarcoma typically occurs during puberty. Studies of the association between height and/or birth-weight and osteosarcoma are conflicting. Therefore, we conducted a large pooled analysis of height and birth-weight in osteosarcoma.
Methods
Patient data from seven studies of height and three of birth-weight were obtained, resulting in 1,067 cases with height and 434 cases with birth-weight data. We compared cases to the 2000 US National Center for Health Statistics Growth Charts by simulating 1,000 age- and gender-matched controls per case. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for associations between height or birth-weight and risk of osteosarcoma for each study were estimated using logistic regression. All of the case data were combined for an aggregate analysis.
Results
Compared to average birth-weight subjects (2,665–4,045 g), individuals with high birth-weight (≥4,046 g) had an increased osteosarcoma risk (OR 1.35, 95% CI 1.01–1.79). Taller than average (51st–89th percentile) and very tall individuals (≥90th percentile) had an increased risk of osteosarcoma (OR 1.35, 95% CI 1.18–1.54 and OR 2.60, 95% CI 2.19–3.07, respectively; P trend < 0.0001).
Conclusions
This is the largest analysis of height at diagnosis and birth-weight in relation to osteosarcoma. It suggests that rapid bone growth during puberty and in utero contributes to OS etiology.
Similar content being viewed by others
References
Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M (2006) Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer AOLM, Barr R, Ries LAG (eds) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda NIH Pub. No. 06-5767, pp 98–109
Dahlin DC, Unni KK (1986) Bone Tumors: general aspects and data on 8, 542 cases, 4th ed edn. Thomas, Springfield
Dorfman HA, Czerniak B (1995) Bone cancers. Cancer Suppl 75:203–210
Fuchs B, Pritchard DJ (2002) Etiology of osteosarcoma. Clin Orthop Relat Res 397:40–52
Hanson MF, Seton M, Merchant A (2006) Osteosarcoma in Paget’s disease of bone. J Bone Miner Res 21:P58–P63
Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313–320
Chauveinc L, Mosseri V, Quintana E et al (2001) Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 22:77–88
Lipton JM, Federman N, Khabbaze Y et al (2001) Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 23:39–44
Wang LL, Gannavarapu A, Kozinetz CA et al (2003) Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 95:669–674
Mirabello L, Troisi RJ, Savage S (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531–1543
Unni KK (1996) Dahlin’s bone tumors: general aspects and data on 11,087 cases. In. 5 edn. Philadelphia: Lippincott-Raven, pp 143–183
Dorfman HA, Czerniak B (1997) Bone tumors. St. Louis, Mosby, pp 128–252
Glass AG, Fraumeni JF (1970) Epidemiology of bone cancer in children. J Natl Cancer Inst 44:187–199
Miller RW (1981) Contrasting epidemiology of childhood osteosarcoma, Ewing’s sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr 56:9–15
Withrow SJ, Powers BE, Straw RC, RM Wilkins (1991) Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 270:159–168
Tjalma RA (1966) Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 36:1137–1150
Fraumeni JF Jr (1967) Stature and malignant tumors of the bone in childhood and adolescence. Cancer 20:967–973
Troisi R, Masters MN, Joshipura K et al (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607
Scranton PE, DeCicco FA, Totten RS, Yunis EJ (1975) Prognostic factors in osteosarcoma. A review of 20 years’ experience at the University of Pittsburgh Health Center Hospitals. Cancer 36:2179–2191
Gelberg KH, Fitzgerald E, Hwang S, Dubrow R (1997) Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol 26:272–278
Rytting M, Pearson P, Raymond AK et al (2000) Osteosarcoma in preadolescent patients. Clin Orthop Relat Res 373:39–50
Ruza E, Sotillo E, Sierrasesúmaga L, Azcona C, Patiño-Garcia A (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 25:780–786
Cotterill SJ, Wright CM, Pearce MS, Craft AW (2004) Stature of young people with malignant bone tumors. Pediatr Blood Cancer 42:59–63
Longhi A, Pasini A, Cicognami A et al (2005) Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27:314–318
Goodman MA, McMaster JH, Drash AL et al (1978) Metabolic and endocrine alterations in osteosarcoma patients. Cancer 42:603–610
Broström LA, Adamson U, Filipsson R, Hall K (1979) Longitudinal growth and dental development in osteosarcoma patients. Acta Orthop Scand 51:755–759
Vassilopoulou-Sellin R, Wallis CJ, Samaan NA (1985) Hormonal evaluation in patients with osteosarcoma. J Surg Oncol 28:209–213
Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR (1987) A case-control study of osteosarcoma in young persons. Am J Epidemiol 126:118–126
Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499
Glasser DB, Duane K, Lane JM, Healey JH, Caparros-Sison B (1991) The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop Relat Res 262:93–100
Buckley JD, Pendergrass TW, Buckley CM et al (1998) Epidemiology of osteosarcoma and Ewing’s sarcoma in children: a study of 305 cases by the Children’s Cancer Group. Cancer 83:1440–1448
Cool WP, Grimer RJ, Carter SR, Tillman RM, Davies AM (1998) Longitudinal growth following treatment for osteosarcoma. Sarcoma 2:115–119
Hartley AL, Birch JM, McKinney PA et al (1988) The inter-regional epidemiological study of childhood cancer (IRESCC): case control study of children with bone and soft tissue sarcomas. Br J Cancer 58:838–842
Schüz J, Forman MR (2007) Birthweight by gestational age and childhood cancer. Cancer Causes Control 18:655–663
Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639
Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11:1–190
Hernández M, Castellet J, Narvaiza JL et al (1988) Curvas y tablas de crecimiento. Instituto de investigación sobre crecimiento y desarrollo. Orbegozo Editorial Garsi, Fundación F. Madrid
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Higgins JP (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:1158–1160
Egger M, Davey-Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634
Begg CB, Mazumdar M (1994) Operating characteristics of rank correlation test for publication bias. Biometrics 50:1088–1101
Hjalgrim LL, Westergaard T, Rostgaard K et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158:724–735
Harder T, Plagemann A, Harder A (2008) Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol 168:366–373
Harder T, Plagemann A, Harder A (2010) Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 39:746–756
Ognjanovic S, Carozza SE, Chow EJ et al. (2009) Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer Dec 8. [Epub ahead of print]
Leisenring WM, Breslow NE, Evans IE et al (1994) Increased birth weights of National Wilms’ Tumor Study patients suggest a growth factor excess. Cancer Res 54:4680–4683
Schüz J, Schmidt LS, Kogner P et al. (2010) Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study. Int J Cancer [Epub ahead of print]
Smith A, Lightfoot T, Simpson J, Roman E, UKCCS investigators (2009) Birth weight, sex and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol Biomarkers Prev 33:363–367
Crowther NJ, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486
Ross JA, Perentesis JP, Robison LL, Davies SM (1996) Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 7:553–559
Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141–169
Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3:298–302
Lagiou P, Hsieh CC, Lipworth L et al (2009) Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 100:1794–1798
Raqib R, Alam DS, Sarker P et al (2007) Low birth weight is associated with altered immune function in rural Bangladeshi children: a birth cohort study. Am J Clin Nutr 85:845–852
Charalambous M, da Rocha ST, Ferguson-Smith AC (2007) Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr Opin Endocrinol Diabetes Obes 14:3–12
Michels KB, Xue F (2006) Role of birth weight in the etiology of breast cancer. Int J Cancer 119:2007–2025
Eriksson M, Wedel H, Wallander MA et al (2007) The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67:1247–1254
Cnattingius S, Lundberg F, Sandin S, Grönberg H, Iliadou A (2009) Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 18:2422–2426
Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Part I. Arch Dis Child 41:454–471
Larsson SE, Lorentzon R (1974) The incidence of malignant primary bone tumours in relation to age, sex and site—a study of osteogenic sarcoma, chondrosarcoma and Ewing’s sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg 56-B:534–540
Price CHG (1958) Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg 408:574–593
Fraumeni JF Jr, Boice JD (1982) Bone. In: DFJJ Schottenfeld (ed) Cancer epidemiology and prevention. W B Saunders Co, Philadelphia
Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125:229–234
Ru G, Terracini B, Glickman LT (1998) Host related risk factors for canine osteosarcoma. Vet J 156:31–39
Ruddon RW (1987) Cancer biology. Oxford University Press, New York
Savage SA, Woodson K, Walk E et al (2007) Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667–1674
Kappel CC, Velez-Yanguas MC, Hirschfeld S, Helman LJ (1994) Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54:2803–2807
Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518
Acknowledgments
This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics and the Center for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mirabello, L., Pfeiffer, R., Murphy, G. et al. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control 22, 899–908 (2011). https://doi.org/10.1007/s10552-011-9763-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9763-2